1 Treatments versus placebo, treatment failure |
4 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.1 Ciclopiroxolamine versus placebo. Outcomes at 48 weeks |
2 |
460 |
Risk Ratio (M‐H, Random, 95% CI) |
0.32 [0.20, 0.52] |
1.2 Fungoid Tincture versus Placebo. Outcomes at 12 months |
1 |
20 |
Risk Ratio (M‐H, Random, 95% CI) |
0.17 [0.02, 1.14] |
1.3 Butenafine 2% & tea tree oil vs placebo. Outcomes at 36 weeks |
1 |
60 |
Risk Ratio (M‐H, Random, 95% CI) |
0.03 [0.00, 0.47] |
2 Comparisons between active treatments, treatment failure |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
2.1 Amorolfine 5% + methylene versus Amorolfine 5% + ethanol outcomes at 3 days |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |